Edited Books

• Talley, N., Segal, I., Weltman, M. (2008). Gastroenterology and Hepatology: a clinical handbook. Australia: Elsevier.

Book Chapters

• Milne, B., Bell, J., Weltman, M., Lampropoulos, B., Towns, S. (2009). Alcohol, drugs and Australian young people. In Bennet, D; Towns, S; Elliot, E; Merrick, J. (Eds.), Challenges in Adolescent Health: An Australian Perspective, (pp. 163-175). United States: Nova Science Publishers.
• Weltman, M., Darke, J. (2008). Acute liver failure. In N Talley, I Segal, M Weltman (Eds.), Gastroenterology and Hepatology: a clinical handbook, (pp. 491-501). Australia: Elsevier.
• Weltman, M. (2008). Obesity and Abnormal Liver Function Tests. In N Talley, I Segal, M Weltman (Eds.), Gastroenterology and Hepatology: a clinical handbook, (pp. 411-420). Australia: Elsevier.
• Weltman, M. (2008). Occult gastrointestinal bleeding and iron deficiency anemia. In N Talley, I Segal, M Weltman (Eds.), Gastroenterology and Hepatology: a clinical handbook, (pp. 246-259). Australia: Elsevier.

Journals

• Walker, M., Aggarwal, K., Shim, L., Bassan, M., Kalantar, J., Weltman, M., Jones, M., Powell, N., Talley, N. (2014). Duodenal eosinophilia and early satiety in functional dyspepsia: Confirmation of a positive association in an Australian cohort. Journal of Gastroenterology and Hepatology, 29(3), 474-479. [More Information]
• Milner, K., Jenkins, A., Trenell, M., Tid-Ang, J., Samocha-Bonet, D., Weltman, M., Xu, A., George, J., Chisholm, D. (2014). Eradicating hepatitis C virus ameliorates insulin resistance without change in adipose depots. Journal of Viral Hepatitis, 21(5), 325-332. [More Information]
• Gibson, P., Vaizey, C., Black, C., Nicholls, R., Weston, A., Bampton, P., Sparrow, M., Lawrance, I., Selby, W., et al, Weltman, M. (2014). Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: A cross-sectional, observational study. Journal of Crohn's and Colitis, 8(7), 598-606. [More Information]
• Koloski, N., Jones, M., Kalantar, J., Weltman, M., Zaguirre, J., Talley, N. (2012). The brain-gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut (English Edition): an international journal of gastroenterology and hepatology, 61(9), 1284-1290. [More Information]
• Sasadeusz, J., Dore, G., Kronborg, I., Barton, D., Yoshihara, M., Weltman, M. (2011). Clinical experience with the treatment of hepatitis C infection in patients on opioid pharmacotherapy. Addiction, 106(5), 977-984. [More Information]
• Baleriola, C., Rawlinson, W., Dore, G., Chaverot, S., Stelzer-Braid, S., Yoshihara, M., Crawford, D., Sievert, W., McCaughan, G., Weltman, M., et al (2011). Effect of low-level HCV viraemia at week 24 on HCV treatment response in genotype 1 patients. Antiviral Therapy, 16(2), 173-180. [More Information]
• Thomson, A., Kwok, R., Weltman, M. (2011). Genetic evaluation of polyposis. Current Colorectal Cancer Reports, 7(1), 8-15. [More Information]
• Smith, K., Suppiah, V., O'Connor, K., Berg, T., Weltman, M., Abate, M., Spengler, U., Bassendine, M., Matthews, G., Irving, W., Ahlenstiel, G., Stewart, G., George, J., Booth, D., et al (2011). Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort. Genome Medicine, 3(8), 57-1-57-13. [More Information]
• Suppiah, V., Gaudieri, S., Armstrong, N., O'Connor, K., Berg, T., Weltman, M., Abate, M., Spengler, U., Bassendine, M., Dore, G., Ahlenstiel, G., Stewart, G., George, J., Booth, D., et al (2011). IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study. PLoS Medicine, 8(9), e1001092-1-e1001092-8. [More Information]
• Dawes, G., Sitharthan, T., Conigrave, K., Phung, N., Weltman, M. (2011). Patients admitted for inpatient cannabis detoxification: withdrawal symptoms and impacts of common comorbidities. Journal of Substance Use, 16(5), 392-405. [More Information]
• Shim, L., Eslick, G., Simring, A., Murray, H., Weltman, M. (2011). The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD). Journal of Crohn's and Colitis, 5(3), 234-238. [More Information]
• Sievert, W., Dore, G., McCaughan, G., Yoshihara, M., Crawford, D., Cheng, W., Weltman, M., Rawlinson, W., Rizkalla, B., DePamphilis, J., et al (2011). Virological Response is Associated with Decline in Hemoglobin Concentration During Pegylated Interferon and Ribavirin Therapy in Hepatitis C Virus Genotype 1. Hepatology, 53(4), 1109-1117. [More Information]
• Milner, K., van der Poorten, D., Trenell, M., Jenkins, A., Xu, A., Smythe, G., Dore, G., Zekry, A., Weltman, M., Fragomeli, V., George, J., et al (2010). Chronic Hepatitis C is Associated with Peripheral rather than Hepatic Insulin Resistance. Gastroenterology, 138(3), 932-941. [More Information]
• Thomson, A., Weltman, M. (2010). Electronic images of the month. Severe duodenitis after massive chronic Ibuprofen overdose. Clinical Gastroenterology and Hepatology, 8(11), e114. [More Information]
• Cheng, W., Roberts, S., McCaughan, G., Sievert, W., Weltman, M., Crawford, D., Rawlinson, W., Marks, P., Thommes, J., Rizkalla, B., et al (2010). Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing. Journal of Hepatology, 53(4), 616-623. [More Information]
• Brzozowska, M., Ostapowicz, G., Weltman, M. (2009). An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome. Journal of Gastroenterology and Hepatology, 24(2), 243-247. [More Information]
• Roberts, S., Weltman, M., Crawford, D., McCaughan, G., Sievert, W., Cheng, W., Rawlinson, W., Desmond, P., Marks, P., Yoshihara, M., et al (2009). Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial. Hepatology, 50(4), 1045-1055. [More Information]
• Richardson, K., Baillie, A., Reid, S., Morley, K., Teesson, M., Sannibale, C., Weltman, M., Haber, P. (2008). Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol? Addiction, 103(6), 953-959. [More Information]
• Razali, K., Thein, H., Bell, J., Cooper-Stanbury, M., Dolan, K., Dore, G., George, J., Kaldore, J., Karvelas, M., Li, J., Weltman, M., et al (2007). Modelling the hepatitis C virus epidemic in Australia. Drug and Alcohol Dependence, 91(39509), 228-235. [More Information]
• Richardson, M., Jonsson, J., Powell, E., Brunt, E., Neuschwander-Tetri, B., Bhathal, P., Dixon, J., Weltman, M., Tilg, H., Moschen, A., et al (2007). Progressive Fibrosis in Nonalcoholic Steatohepatitis: Association With Altered Regeneration and a Ductular Reaction. Gastroenterology, 133(1), 80-90. [More Information]
• Morley, K., Teesson, M., Reid, S., Sannibale, C., Thomson, C., Phung, N., Weltman, M., Bell, J., Richardson, K., Haber, P. (2006). Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi-centre, randomized, double-blind, placebo-controlled trial. Addiction, 101(10), 1451-1462. [More Information]
• Richardson, K., Reid, S., Morley, K., Teesson, M., Sannibale, C., Weltman, M., Baillie, A., Haber, P. (2006). The effects of alcohol and naltrexone on craving and alcohol consumption. Alcoholism: Clinical and Experimental Research, 30(s2), 169A-169A.
• Coverdale, S., Khan, M., Byth Wilson, K., Lin, R., Weltman, M., George, J., Samarasinghe, D., Liddle, C., Farrell, G., Kench, J., Crewe, E. (2004). Effects Of Interferon Treatment Response On Liver Complications Of Chronic Hepatitis C: 9-Year Follow-Up Study. American Journal of Gastroenterology, 99(4), 636-644.
• Shaw, D., Williams, R., Cook, I., Wallace, K., Weltman, M., Collins, P., McKay, E., Smart, R., Simula, M. (2004). Oropharyngeal scintigraphy: a reliable technique for the quantitative evaluation of oral-pharyngeal swallowing. Dysphagia: an international multidisciplinary journal devoted to swallowing and its disorders, 19(1), 36-42. [More Information]
• Fuller, S., Kumar, P., Weltman, M., Wiley, J. (2003). Autoimmune hemolysis associated with primary biliary cirrhosis responding to ursodeoxycholic acid as sole treatment. American Journal Of Hematology, 72(1), 31-33. [More Information]
• Chitturi, S., Weltman, M., Farrell, G., McDonald, D., Liddle, C., Samarasinghe, D., Lin, R., Abeygunasekera, S., George, J. (2002). HFE Mutations, Hepatic Iron, and Fibrosis: Ethnic-Specification Association of NASH with C282Y but not with Fibrotic Severity. Hepatology, 36(1), 142-149.
• Chitturi, S., Abeygunasekera, S., Farrell, G., Holmes-Walker, J., Hui, J., Fung, C., Karim, R., Lin, R., Samarasinghe, D., Liddle, C., Weltman, M., George, J. (2002). NASH and Insulin Resistance: Insulin Hypersecretion and Specific Association with the Insulin Resistance Syndrome. Hepatology, 35(2), 373-379.
• Chitturi, S., Abeygunasekera, S., Fung, C., Samarasinghe, D., Lin, R., McDonald, D., Weltman, M., Farrell, G., George, J. (2001). Haemochromatosis gene mutations, hepatic iron content and nonalcoholic steatohepatitis. Hepatology, 19, 1768-1778.

2014

• Walker, M., Aggarwal, K., Shim, L., Bassan, M., Kalantar, J., Weltman, M., Jones, M., Powell, N., Talley, N. (2014). Duodenal eosinophilia and early satiety in functional dyspepsia: Confirmation of a positive association in an Australian cohort. Journal of Gastroenterology and Hepatology, 29(3), 474-479. [More Information]
• Milner, K., Jenkins, A., Trenell, M., Tid-Ang, J., Samocha-Bonet, D., Weltman, M., Xu, A., George, J., Chisholm, D. (2014). Eradicating hepatitis C virus ameliorates insulin resistance without change in adipose depots. Journal of Viral Hepatitis, 21(5), 325-332. [More Information]
• Gibson, P., Vaizey, C., Black, C., Nicholls, R., Weston, A., Bampton, P., Sparrow, M., Lawrance, I., Selby, W., et al, Weltman, M. (2014). Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: A cross-sectional, observational study. Journal of Crohn's and Colitis, 8(7), 598-606. [More Information]

2012

• Koloski, N., Jones, M., Kalantar, J., Weltman, M., Zaguirre, J., Talley, N. (2012). The brain-gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut (English Edition): an international journal of gastroenterology and hepatology, 61(9), 1284-1290. [More Information]

2011

• Sasadeusz, J., Dore, G., Kronborg, I., Barton, D., Yoshihara, M., Weltman, M. (2011). Clinical experience with the treatment of hepatitis C infection in patients on opioid pharmacotherapy. Addiction, 106(5), 977-984. [More Information]
• Baleriola, C., Rawlinson, W., Dore, G., Chaverot, S., Stelzer-Braid, S., Yoshihara, M., Crawford, D., Sievert, W., McCaughan, G., Weltman, M., et al (2011). Effect of low-level HCV viraemia at week 24 on HCV treatment response in genotype 1 patients. Antiviral Therapy, 16(2), 173-180. [More Information]
• Thomson, A., Kwok, R., Weltman, M. (2011). Genetic evaluation of polyposis. Current Colorectal Cancer Reports, 7(1), 8-15. [More Information]
• Smith, K., Suppiah, V., O'Connor, K., Berg, T., Weltman, M., Abate, M., Spengler, U., Bassendine, M., Matthews, G., Irving, W., Ahlenstiel, G., Stewart, G., George, J., Booth, D., et al (2011). Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort. Genome Medicine, 3(8), 57-1-57-13. [More Information]
• Suppiah, V., Gaudieri, S., Armstrong, N., O'Connor, K., Berg, T., Weltman, M., Abate, M., Spengler, U., Bassendine, M., Dore, G., Ahlenstiel, G., Stewart, G., George, J., Booth, D., et al (2011). IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study. PLoS Medicine, 8(9), e1001092-1-e1001092-8. [More Information]
• Dawes, G., Sitharthan, T., Conigrave, K., Phung, N., Weltman, M. (2011). Patients admitted for inpatient cannabis detoxification: withdrawal symptoms and impacts of common comorbidities. Journal of Substance Use, 16(5), 392-405. [More Information]
• Shim, L., Eslick, G., Simring, A., Murray, H., Weltman, M. (2011). The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD). Journal of Crohn's and Colitis, 5(3), 234-238. [More Information]
• Sievert, W., Dore, G., McCaughan, G., Yoshihara, M., Crawford, D., Cheng, W., Weltman, M., Rawlinson, W., Rizkalla, B., DePamphilis, J., et al (2011). Virological Response is Associated with Decline in Hemoglobin Concentration During Pegylated Interferon and Ribavirin Therapy in Hepatitis C Virus Genotype 1. Hepatology, 53(4), 1109-1117. [More Information]

2010

• Milner, K., van der Poorten, D., Trenell, M., Jenkins, A., Xu, A., Smythe, G., Dore, G., Zekry, A., Weltman, M., Fragomeli, V., George, J., et al (2010). Chronic Hepatitis C is Associated with Peripheral rather than Hepatic Insulin Resistance. Gastroenterology, 138(3), 932-941. [More Information]
• Thomson, A., Weltman, M. (2010). Electronic images of the month. Severe duodenitis after massive chronic Ibuprofen overdose. Clinical Gastroenterology and Hepatology, 8(11), e114. [More Information]
• Cheng, W., Roberts, S., McCaughan, G., Sievert, W., Weltman, M., Crawford, D., Rawlinson, W., Marks, P., Thommes, J., Rizkalla, B., et al (2010). Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing. Journal of Hepatology, 53(4), 616-623. [More Information]

2009

• Milne, B., Bell, J., Weltman, M., Lampropoulos, B., Towns, S. (2009). Alcohol, drugs and Australian young people. In Bennet, D; Towns, S; Elliot, E; Merrick, J. (Eds.), Challenges in Adolescent Health: An Australian Perspective, (pp. 163-175). United States: Nova Science Publishers.
• Brzozowska, M., Ostapowicz, G., Weltman, M. (2009). An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome. Journal of Gastroenterology and Hepatology, 24(2), 243-247. [More Information]
• Roberts, S., Weltman, M., Crawford, D., McCaughan, G., Sievert, W., Cheng, W., Rawlinson, W., Desmond, P., Marks, P., Yoshihara, M., et al (2009). Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial. Hepatology, 50(4), 1045-1055. [More Information]

2008

• Weltman, M., Darke, J. (2008). Acute liver failure. In N Talley, I Segal, M Weltman (Eds.), Gastroenterology and Hepatology: a clinical handbook, (pp. 491-501). Australia: Elsevier.
• Richardson, K., Baillie, A., Reid, S., Morley, K., Teesson, M., Sannibale, C., Weltman, M., Haber, P. (2008). Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol? Addiction, 103(6), 953-959. [More Information]
• Talley, N., Segal, I., Weltman, M. (2008). Gastroenterology and Hepatology: a clinical handbook. Australia: Elsevier.
• Weltman, M. (2008). Obesity and Abnormal Liver Function Tests. In N Talley, I Segal, M Weltman (Eds.), Gastroenterology and Hepatology: a clinical handbook, (pp. 411-420). Australia: Elsevier.
• Weltman, M. (2008). Occult gastrointestinal bleeding and iron deficiency anemia. In N Talley, I Segal, M Weltman (Eds.), Gastroenterology and Hepatology: a clinical handbook, (pp. 246-259). Australia: Elsevier.

2007

• Razali, K., Thein, H., Bell, J., Cooper-Stanbury, M., Dolan, K., Dore, G., George, J., Kaldore, J., Karvelas, M., Li, J., Weltman, M., et al (2007). Modelling the hepatitis C virus epidemic in Australia. Drug and Alcohol Dependence, 91(39509), 228-235. [More Information]
• Richardson, M., Jonsson, J., Powell, E., Brunt, E., Neuschwander-Tetri, B., Bhathal, P., Dixon, J., Weltman, M., Tilg, H., Moschen, A., et al (2007). Progressive Fibrosis in Nonalcoholic Steatohepatitis: Association With Altered Regeneration and a Ductular Reaction. Gastroenterology, 133(1), 80-90. [More Information]

2006

• Morley, K., Teesson, M., Reid, S., Sannibale, C., Thomson, C., Phung, N., Weltman, M., Bell, J., Richardson, K., Haber, P. (2006). Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi-centre, randomized, double-blind, placebo-controlled trial. Addiction, 101(10), 1451-1462. [More Information]
• Richardson, K., Reid, S., Morley, K., Teesson, M., Sannibale, C., Weltman, M., Baillie, A., Haber, P. (2006). The effects of alcohol and naltrexone on craving and alcohol consumption. Alcoholism: Clinical and Experimental Research, 30(s2), 169A-169A.

2004

• Coverdale, S., Khan, M., Byth Wilson, K., Lin, R., Weltman, M., George, J., Samarasinghe, D., Liddle, C., Farrell, G., Kench, J., Crewe, E. (2004). Effects Of Interferon Treatment Response On Liver Complications Of Chronic Hepatitis C: 9-Year Follow-Up Study. American Journal of Gastroenterology, 99(4), 636-644.
• Shaw, D., Williams, R., Cook, I., Wallace, K., Weltman, M., Collins, P., McKay, E., Smart, R., Simula, M. (2004). Oropharyngeal scintigraphy: a reliable technique for the quantitative evaluation of oral-pharyngeal swallowing. Dysphagia: an international multidisciplinary journal devoted to swallowing and its disorders, 19(1), 36-42. [More Information]

2003

• Fuller, S., Kumar, P., Weltman, M., Wiley, J. (2003). Autoimmune hemolysis associated with primary biliary cirrhosis responding to ursodeoxycholic acid as sole treatment. American Journal Of Hematology, 72(1), 31-33. [More Information]

2002

• Chitturi, S., Weltman, M., Farrell, G., McDonald, D., Liddle, C., Samarasinghe, D., Lin, R., Abeygunasekera, S., George, J. (2002). HFE Mutations, Hepatic Iron, and Fibrosis: Ethnic-Specification Association of NASH with C282Y but not with Fibrotic Severity. Hepatology, 36(1), 142-149.
• Chitturi, S., Abeygunasekera, S., Farrell, G., Holmes-Walker, J., Hui, J., Fung, C., Karim, R., Lin, R., Samarasinghe, D., Liddle, C., Weltman, M., George, J. (2002). NASH and Insulin Resistance: Insulin Hypersecretion and Specific Association with the Insulin Resistance Syndrome. Hepatology, 35(2), 373-379.

2001

• Chitturi, S., Abeygunasekera, S., Fung, C., Samarasinghe, D., Lin, R., McDonald, D., Weltman, M., Farrell, G., George, J. (2001). Haemochromatosis gene mutations, hepatic iron content and nonalcoholic steatohepatitis. Hepatology, 19, 1768-1778.